Geoffrey R. Krouse

Since August 2016, Geoff Krouse has served as the Assistant Dean for Alumni & Development and a Senior Lecturing Fellow at Duke Law School. Geoff is teaching a course on mergers and acquisitions in the spring semester. 

Geoff joined Smith Anderson in May 2005, after almost eight years of practicing in the areas of corporate finance, mergers and acquisitions, securities law and private equity n the New York office of one of the world's largest law firms.

While he was a partner at Smith Anderson, Geoff’s practice included representing public and private companies in mergers and acquisitions and recapitalization transactions, public offerings and private placements of securities, and other corporate and compliance matters. He has experience working with a variety of clients including public and private companies, investment banks and private equity firms in industries such as pharmaceutical services, technology and energy, among others.  

In his role as Of Counsel, Geoff continues to advise clients in a variety of corporate matters. 

Recognition

• The Best Lawyers in America®, Mergers and Acquisitions Law (2013-2025)
• North Carolina Super Lawyers Rising Star (2010 & 2011)

Education

• Duke University, J.D., 1997
• Duke University, B.A., 1993

Bar & Court Admissions

• Association for Corporate Growth (RTP Chapter), Board Member (2011-2014)
• Duke Law School Alumni Association, Board of Directors (Past Member)
• Duke Law School Start-Up Ventures Clinic, Attorney Mentor
• Freedom United, Board of Directors (2016-2018)
• Montessori School of Raleigh, Board of Trustees (2014-2017)
• Ronald McDonald House of Durham and Wake, Board of Directors (2010-2016) and Past President (2012-2014)
• North Carolina Bar Association
• Wake County Bar Association

• Represented a leading international developer of video games and game engine software in significant minority investment by a Chinese internet company.
• Represented a publicly-traded business development company in connection with various mezzanine debt and equity investments.
• Represented a healthcare investment fund in connection with initial fund formation for a biopharmaceutical-focused private equity firm.
• Represented a global provider of biopharmaceutical development services and commercial outsourcing services in connection with $1.6 billion private equity recapitalization transaction.
• Represented a global pharmaceutical services company in connection with acquisition of Latin American clinical research organization business.
• Represented a company focused on investment and collaborative transactions in biopharmaceuticals and related industries in connection with share repurchase transaction.
• Represented a publicly-traded company and leading producer of construction aggregates in the U.S. in connection with acquisition of Western-based aggregates business.